26 years of historical data (1999–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cross Country Healthcare, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 2.5x P/FCF, 67% below the 5-year average of 7.7x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $281M | $606M | $803M | $997M | $1.0B | $320M | $416M | $261M | $461M | $566M | $527M |
| Enterprise Value | $203M | $528M | $791M | $1.2B | $1.2B | $397M | $510M | $329M | $535M | $632M | $615M |
| P/E Ratio → | -19.77 | — | 11.04 | 5.29 | 7.86 | — | — | — | 12.63 | 104.07 | 117.07 |
| P/S Ratio | 0.21 | 0.45 | 0.40 | 0.36 | 0.62 | 0.38 | 0.51 | 0.32 | 0.53 | 0.68 | 0.69 |
| P/B Ratio | 0.69 | 1.45 | 1.70 | 2.18 | 3.49 | 2.07 | 2.55 | 1.20 | 1.94 | 3.73 | 3.73 |
| P/FCF | 2.52 | 5.44 | 3.42 | 7.96 | — | 14.17 | 159.94 | 15.94 | 11.42 | 23.95 | 33.21 |
| P/OCF | 2.34 | 5.05 | 3.23 | 7.44 | — | 11.77 | 75.09 | 12.45 | 10.14 | 18.77 | 28.91 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Cross Country Healthcare, Inc.'s enterprise value stands at 319.8x EBITDA, 12% below its 5-year average of 363.1x. The Healthcare sector median is 13.8x, placing the stock at a 2210% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.39 | 0.39 | 0.41 | 0.74 | 0.47 | 0.62 | 0.40 | 0.62 | 0.76 | 0.80 |
| EV / EBITDA | 319.77 | 832.13 | 6.04 | 4.08 | 8.29 | 964.73 | — | — | 24.41 | 41.14 | 21.46 |
| EV / EBIT | — | — | 7.13 | 4.30 | 8.49 | 24.30 | 57.52 | — | 62.84 | 19.67 | 22.74 |
| EV / FCF | — | 4.74 | 3.37 | 9.19 | — | 17.55 | 196.03 | 20.03 | 13.25 | 26.76 | 38.72 |
Margins and return-on-capital ratios measuring operating efficiency
Cross Country Healthcare, Inc. earns an operating margin of -1.3%. Operating margins have compressed from 9.6% to -1.3% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -3.3% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.4% | 20.4% | 22.3% | 22.3% | 22.4% | 24.2% | 24.8% | 25.7% | 26.4% | 26.6% | 25.7% |
| Operating Margin | -1.3% | -1.3% | 5.6% | 9.6% | 8.3% | -1.1% | -1.9% | -1.6% | 1.4% | 0.7% | 2.7% |
| Net Profit Margin | -1.1% | -1.1% | 3.6% | 6.6% | 7.9% | -1.5% | -7.0% | -2.1% | 4.3% | 1.0% | 0.6% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.3% | -3.3% | 15.6% | 49.3% | 58.4% | -8.1% | -30.2% | -7.4% | 19.3% | 5.4% | 3.3% |
| ROA | -2.3% | -2.3% | 8.9% | 22.1% | 24.2% | -3.5% | -14.3% | -3.8% | 8.8% | 2.1% | 1.3% |
| ROIC | -3.2% | -3.2% | 15.8% | 36.7% | 28.9% | -2.8% | -4.3% | -3.2% | 3.3% | 2.1% | 7.2% |
| ROCE | -3.4% | -3.4% | 18.7% | 44.6% | 35.0% | -3.3% | -4.9% | -3.6% | 3.5% | 2.2% | 7.6% |
Solvency and debt-coverage ratios — lower is generally safer
Cross Country Healthcare, Inc. carries a Debt/EBITDA ratio of 6.1x, which is highly leveraged (96% above the sector average of 3.1x). The company holds a net cash position — cash of $82M exceeds total debt of $4M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.35 | 0.66 | 0.50 | 0.58 | 0.38 | 0.42 | 0.57 | 0.64 |
| Debt / EBITDA | 6.10 | 6.10 | 0.04 | 0.56 | 1.31 | 189.79 | — | — | 4.52 | 5.66 | 3.14 |
| Net Debt / Equity | — | -0.19 | -0.02 | 0.34 | 0.65 | 0.49 | 0.57 | 0.31 | 0.31 | 0.44 | 0.62 |
| Net Debt / EBITDA | -122.46 | -122.46 | -0.09 | 0.55 | 1.31 | 185.89 | — | — | 3.36 | 4.32 | 3.05 |
| Debt / FCF | — | -0.70 | -0.05 | 1.23 | — | 3.38 | 36.08 | 4.10 | 1.82 | 2.81 | 5.51 |
| Interest Coverage | -7.71 | -7.71 | 13.93 | 18.75 | 20.29 | -3.17 | -2.96 | -2.28 | 2.79 | 1.01 | 3.02 |
Net cash position: cash ($82M) exceeds total debt ($4M)
Short-term solvency ratios and asset-utilisation metrics
Cross Country Healthcare, Inc.'s current ratio of 2.78x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.49x to 2.78x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | 2.78 | 2.79 | 2.49 | 2.54 | 1.96 | 2.15 | 2.28 | 2.21 | 2.12 | 1.84 |
| Quick Ratio | 2.78 | 2.78 | 2.79 | 2.45 | 2.54 | 1.96 | 2.15 | 2.21 | 2.15 | 2.05 | 1.79 |
| Cash Ratio | 0.68 | 0.68 | 0.12 | 0.01 | 0.01 | 0.02 | 0.01 | 0.19 | 0.27 | 0.21 | 0.03 |
| Asset Turnover | — | 2.28 | 2.97 | 2.96 | 2.29 | 2.34 | 2.15 | 1.91 | 1.85 | 2.15 | 2.10 |
| Inventory Turnover | 196.88 | — | — | 196.88 | — | — | — | 97.76 | 120.38 | 99.87 | 126.09 |
| Days Sales Outstanding | — | 65.96 | 70.18 | 85.93 | 108.62 | 76.24 | 77.48 | 76.14 | 74.73 | 77.36 | 71.22 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cross Country Healthcare, Inc. returns 13.3% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 9.1% | 18.9% | 12.7% | — | — | — | 7.9% | 1.0% | 0.9% |
| FCF Yield | 39.7% | 18.4% | 29.2% | 12.6% | — | 7.1% | 0.6% | 6.3% | 8.8% | 4.2% | 3.0% |
| Buyback Yield | 13.3% | 6.2% | 7.2% | 3.5% | 0.2% | 0.2% | 0.2% | 1.9% | 0.4% | 0.0% | 0.1% |
| Total Shareholder Yield | 13.3% | 6.2% | 7.2% | 3.5% | 0.2% | 0.2% | 0.2% | 1.9% | 0.4% | 0.0% | 0.1% |
| Shares Outstanding | — | $33M | $35M | $38M | $37M | $36M | $36M | $36M | $36M | $36M | $32M |
Compare CCRN with 6 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| CCRNYou | $281M | -19.8 | 319.8 | 2.5 | 20.4% | -1.3% | -3.3% | -3.2% | 6.1 |
| SOLV | $13B | 8.4 | 7.8 | — | 53.5% | 26.2% | 38.9% | 16.9% | 2.3 |
| HCSG | $2B | 26.9 | 24.0 | 12.0 | 13.0% | 2.6% | 10.6% | 7.7% | 0.3 |
| AMN | $987M | -5.1 | 29.2 | 4.1 | 30.8% | -3.4% | -19.1% | -3.9% | 15.4 |
| CCEL | $27M | 67.4 | 10.0 | 7.5 | 75.2% | 10.9% | — | — | 3.3 |
| AMS | $14M | 6.4 | 7.7 | — | 32.4% | -9.9% | 7.8% | -5.8% | 6.9 |
| SYRA | $60000 | -0.2 | — | — | 20.7% | -47.2% | -109.1% | -294.7% | — |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 26 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CCRN stacks up against sector leader Solventum Corporation.
Start ComparisonCross Country Healthcare, Inc.'s current P/E ratio is -19.8x. The historical average is 39.2x.
Cross Country Healthcare, Inc.'s current EV/EBITDA is 319.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.2x.
Cross Country Healthcare, Inc.'s return on equity (ROE) is -3.3%. The historical average is 2.3%.
Based on historical data, Cross Country Healthcare, Inc. is trading at a P/E of -19.8x. Compare with industry peers and growth rates for a complete picture.
Cross Country Healthcare, Inc. has 20.4% gross margin and -1.3% operating margin.
Cross Country Healthcare, Inc.'s Debt/EBITDA ratio is 6.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.